Intrinsic Value Partners LLC Acquires 298 Shares of GE HealthCare Technologies Inc. $GEHC

Intrinsic Value Partners LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.0% in the second quarter, HoldingsChannel reports. The firm owned 6,303 shares of the company’s stock after acquiring an additional 298 shares during the period. Intrinsic Value Partners LLC’s holdings in GE HealthCare Technologies were worth $467,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. N.E.W. Advisory Services LLC bought a new stake in GE HealthCare Technologies during the 1st quarter valued at $25,000. Bogart Wealth LLC raised its position in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC raised its position in GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after purchasing an additional 222 shares in the last quarter. Olde Wealth Management LLC bought a new stake in GE HealthCare Technologies during the 1st quarter valued at $35,000. Finally, Zions Bancorporation National Association UT bought a new stake in GE HealthCare Technologies during the 1st quarter valued at $42,000. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a report on Thursday, September 18th. Weiss Ratings reiterated a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Finally, Citigroup lifted their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $86.89.

GE HealthCare Technologies Trading Down 0.3%

Shares of NASDAQ:GEHC opened at $76.56 on Friday. The business’s 50-day moving average is $74.25 and its 200 day moving average is $72.61. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The firm has a market capitalization of $34.95 billion, a P/E ratio of 15.69, a P/E/G ratio of 2.94 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter last year, the company earned $1.00 earnings per share. The company’s quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.